Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19995 | 417 | 43.3 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | A20 | Author keyword | 68 | 57% | 19% | 81 |
| 2 | STRESS ASSOCIATED PROTEIN | Author keyword | 8 | 75% | 1% | 6 |
| 3 | ZINC FINGER PROTEIN A20 | Author keyword | 8 | 75% | 1% | 6 |
| 4 | ABIN | Author keyword | 8 | 100% | 1% | 5 |
| 5 | RNF11 | Author keyword | 7 | 64% | 2% | 7 |
| 6 | UNIT MOL SIGNAL TRANSDUCT INFLAMMAT | Address | 7 | 23% | 6% | 26 |
| 7 | TNIP1 | Author keyword | 7 | 67% | 1% | 6 |
| 8 | TAX1BP1 | Author keyword | 6 | 100% | 1% | 4 |
| 9 | A20 TNFAIP3 | Author keyword | 4 | 67% | 1% | 4 |
| 10 | VASC ENDOVASC SURG VASC BIOL | Address | 4 | 67% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | A20 | 68 | 57% | 19% | 81 | Search A20 | Search A20 |
| 2 | STRESS ASSOCIATED PROTEIN | 8 | 75% | 1% | 6 | Search STRESS+ASSOCIATED+PROTEIN | Search STRESS+ASSOCIATED+PROTEIN |
| 3 | ZINC FINGER PROTEIN A20 | 8 | 75% | 1% | 6 | Search ZINC+FINGER+PROTEIN+A20 | Search ZINC+FINGER+PROTEIN+A20 |
| 4 | ABIN | 8 | 100% | 1% | 5 | Search ABIN | Search ABIN |
| 5 | RNF11 | 7 | 64% | 2% | 7 | Search RNF11 | Search RNF11 |
| 6 | TNIP1 | 7 | 67% | 1% | 6 | Search TNIP1 | Search TNIP1 |
| 7 | TAX1BP1 | 6 | 100% | 1% | 4 | Search TAX1BP1 | Search TAX1BP1 |
| 8 | A20 TNFAIP3 | 4 | 67% | 1% | 4 | Search A20+TNFAIP3 | Search A20+TNFAIP3 |
| 9 | A20 GENE | 4 | 75% | 1% | 3 | Search A20+GENE | Search A20+GENE |
| 10 | AN1 | 4 | 75% | 1% | 3 | Search AN1 | Search AN1 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | A20 BINDING INHIBITOR | 21 | 78% | 3% | 14 |
| 2 | TNFAIP3 A20 | 21 | 71% | 4% | 17 |
| 3 | A20 | 15 | 26% | 12% | 50 |
| 4 | FINGER PROTEIN A20 | 15 | 77% | 2% | 10 |
| 5 | INHIBITS TNF | 13 | 80% | 2% | 8 |
| 6 | SAP GENE FAMILY | 12 | 86% | 1% | 6 |
| 7 | EDITING ENZYME A20 | 9 | 37% | 5% | 19 |
| 8 | UBIQUITIN EDITING ENZYME | 8 | 100% | 1% | 5 |
| 9 | LINEAR POLYUBIQUITIN | 8 | 62% | 2% | 8 |
| 10 | CONFERS TOLERANCE | 7 | 34% | 4% | 16 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A20 in inflammation and autoimmunity | 2014 | 20 | 97 | 57% |
| A20: linking a complex regulator of ubiquitylation to immunity and human disease | 2012 | 73 | 113 | 49% |
| Regulation of NF-kappa B signaling by the A20 deubiquitinase | 2012 | 46 | 101 | 55% |
| Regulation of NF-kappa B by deubiquitinases | 2012 | 81 | 168 | 28% |
| A20: Central Gatekeeper in Inflammation and Immunity | 2009 | 109 | 66 | 59% |
| Expression, biological activities and mechanisms of action of A20 (TNFAIP3) | 2010 | 58 | 129 | 64% |
| The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology | 2009 | 160 | 83 | 33% |
| Deubiquitinases in the regulation of NF-kappa B signaling | 2011 | 87 | 183 | 26% |
| Regulation of nuclear factor-kappa B in autoimmunity | 2013 | 13 | 80 | 20% |
| A20: from ubiquitin editing to tumour suppression | 2010 | 92 | 37 | 27% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNIT MOL SIGNAL TRANSDUCT INFLAMMAT | 7 | 23% | 6.2% | 26 |
| 2 | VASC ENDOVASC SURG VASC BIOL | 4 | 67% | 1.0% | 4 |
| 3 | SHENZHEN ENT | 1 | 38% | 0.7% | 3 |
| 4 | SOUTH BLDG | 1 | 100% | 0.5% | 2 |
| 5 | SHENZHEN ALLERGY IMMUNOL | 1 | 27% | 1.0% | 4 |
| 6 | BRAIN TUMOR NEUROL | 1 | 33% | 0.5% | 2 |
| 7 | DOCTOR PHARM PROGRAM | 1 | 21% | 0.7% | 3 |
| 8 | BIOCHEM CVK | 1 | 50% | 0.2% | 1 |
| 9 | BIOL CHEM MOL PHARMACOLPROGRAM CELLULAR | 1 | 50% | 0.2% | 1 |
| 10 | MED CARDIOVASC DIABET MED | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000168936 | TAK1//TRAF4//TRAF5 |
| 2 | 0.0000140221 | DSK2//UBIQUILIN 1//LUBAC |
| 3 | 0.0000138992 | PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//IRF5 |
| 4 | 0.0000129052 | BCL10//PKC THETA//CARMA3 |
| 5 | 0.0000108621 | WWP1//SMURF1//CKIP 1 |
| 6 | 0.0000097034 | CELL DECIS PROC//MATH ARTS SCI//SIGNALING SYST |
| 7 | 0.0000086057 | I KAPPA B//IKK//C REL |
| 8 | 0.0000077543 | USP22//UCH L1//DEUBIQUITINATING ENZYME |
| 9 | 0.0000070284 | TPL2//TPL 2//TPL2 KINASE |
| 10 | 0.0000068100 | STEAP4//STAMP2//STEAP |